Aerie Pharmaceuticals reported $58.69M in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Adamas Pharmaceuticals ADMS:US 31.13M 2.29M
Aerie Pharmaceuticals AERI:US $ 58.69M 1.5M
Alimera Sciences ALIM:US $ 12.91M 736K
Amarin AMRN:US 145.72M 2.21M
Antares Pharma ATRS:US $ 38.19M 1.5M
Bluebird Bio BLUE:US $ 248.31M 4.31M
Cara Therapeutics CARA:US $ 30.88M 5.38M
Coherus Biosciences CHRS:US $ 111.81M 138.59M
Endo International Ordinary Shares ENDP:US $ 570.72M 35.49M
Flexion Therapeutics FLXN:US $ 45.06M 2.67M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Horizon Pharma HZNP:US $ 694.03M 191.61M
Insmed INSM:US $ 151.62M 27.57M
JAZZ PHA JAZZ:US $ 821.4M 375.94M
Merk MRK:US $ 9788M 722M
Mirati Therapeutics MRTX:US $ 164.19M 31.76M
Novartis NOVN:VX 9.82B 464M
Pacira Pharmaceuticals PCRX:US $ 100.75M 1.16M
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M
Revance Therapeutics RVNC:US $ 89.14M 5.83M
Supernus Pharmaceuticals SUPN:US $ 107.22M 10.5M
Teva Pharmaceutical Industries TEVA:US 3.26B 64M
Valeant Pharmaceuticals VRX:CN C$ 2.42B 162M
Zoetis ZTS:US $ 1.31B 128M
Zogenix ZGNX:US $ 74.22M 8.73M